Full-Time

Director/Senior Director

Regulatory CMC

Confirmed live in the last 24 hours

Beam Therapeutics

Beam Therapeutics

501-1,000 employees

Develops precision genetic medicines using base editing

Biotechnology
Healthcare

Senior, Expert

Cambridge, MA, USA

Candidates are expected to come onsite 1-3 days per week.

Category
Risk & Compliance
Legal & Compliance

You match the following Beam Therapeutics's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • BA/BS degree in a scientific/engineering discipline with 15+ years experience, 10 of which in the biotech industry; Level will be commensurate with experience
  • 9+ years experience in Regulatory CMC, or related experience (e.g., manufacturing, analytical, quality assurance) with direct technical writing experience for IND/CTA/MF and BLA/MAA submissions
  • Comprehensive knowledge of regulatory (FDA, EMA, and ICH) guidelines; with a demonstrated ability to articulate and apply these principles to regulatory CMC strategies for novel products
  • Strong experience with CTD format and content regulatory filings
  • Excellent organizational, written/oral communication, and time management skills; ability to communicate complex issues in a succinct and logical manner; strong listening skills
  • Experience with related CMC disciplines (e.g., manufacturing, analytical, quality assurance) and the ability to be creative and imaginative in the approach to new and diverse problem solving
  • Ability to generate innovative solutions to complex regulatory problems and effectively work with and communicate to key stakeholders; flexibility in responding to changing priorities and/or unexpected events
Responsibilities
  • Provide regulatory CMC strategic leadership within Regulatory and on cross-functional teams to support development of innovative genomic medicines/ex-vivo and in-vivo therapies
  • Develop and proactively communicate regulatory CMC strategies, risks and key issues in an evolving regulatory landscape
  • Act as the regulatory CMC lead and department representative in matrix teams for development programs
  • Support development of manufacturing, analytical, and supply chain strategies and provide expert regulatory guidance to enable global implementation
  • Define CMC content (data and documentation) requirements for quality sections of regulatory dossiers (IND/CTA/MF and BLA/MAA)
  • Plan and manage activities for the preparation of high quality CMC-related global regulatory submission elements, including authoring and/or critical review to ensure compliance with regulatory requirements, scientific excellence, accuracy, source information traceability, and consistency with related filings in accordance with program timelines
  • Providing critical review of detailed scientific information described in CMC documents and assessing whether technical arguments are presented clearly and conclusions are adequately supported by data
  • Evaluation of CMC-related change proposals for regulatory impact and filing requirements; provide strategic regulatory guidance for optimal implementation of changes
  • Develop regulatory processes and procedures to support CMC components of regulatory submissions
  • Support the creation and maintenance of CMC submission templates and dossier standards
  • Lead and support global health authority interactions for CMC-related topics including defining strategy, preparation, and meeting facilitation
  • Support Quality Assurance in preparing and hosting GMP and pre-approval inspections
  • Develops and maintains collaborative partnerships with key internal and external stakeholders
  • Participate in regulatory intelligence activities, monitor regulatory guidelines and trends as they pertain to global CMC regulations and guidance, and provide regulatory advice to CMC and project teams regarding the applicability/impact on internal programs; anticipate and communicate possible regulatory paradigm shifts
Desired Qualifications
  • Experience with cell and gene therapy and/or lipid nanoparticles is desirable
  • Diverse experience including biologics in the cell therapy space, drugs, and international filings preferred

Beam Therapeutics develops precision genetic medicines using a technique called base editing, which allows for precise modifications to the genetic code to potentially correct mutations that lead to serious diseases. Their primary focus is on treating genetic disorders, such as sickle cell disease, with the aim of providing lifelong cures rather than just temporary solutions. The company invests significantly in research and development to create new therapies and generates revenue through partnerships, licensing agreements, and future commercialization of their treatments. Unlike many competitors, Beam Therapeutics emphasizes collaboration with pharmaceutical companies and research institutions, which helps them secure funding and support for their projects. The ultimate goal of Beam Therapeutics is to advance scientific research and deliver effective, long-lasting treatments for patients suffering from genetic conditions.

Company Stage

IPO

Total Funding

$215.9M

Headquarters

Cambridge, Massachusetts

Founded

2017

Growth & Insights
Headcount

6 month growth

0%

1 year growth

-1%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Base editing technology is gaining traction as a precise genetic correction method.
  • The $250 million deal with Eli Lilly boosts Beam's financial and strategic position.
  • Christi Shaw's appointment to the board brings valuable biotech leadership.

What critics are saying

  • Competition from CRISPR Therapeutics could impact Beam's market share.
  • Recent restructuring and layoffs may lead to operational challenges.
  • New CFO transition might pose financial management challenges.

What makes Beam Therapeutics unique

  • Beam Therapeutics uses base editing, a precise genetic correction method.
  • The company focuses on lifelong cures for genetic disorders like sickle cell disease.
  • Beam's strategic partnerships, like with Eli Lilly, enhance its market position.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours